Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. Functional and morphological studies.

PubWeight™: 5.14‹?› | Rank: Top 1%

🔗 View Article (PMC 2188798)

Published in J Exp Med on December 01, 1987

Authors

S E Macatonia1, S C Knight, A J Edwards, S Griffiths, P Fryer

Author Affiliations

1: Division of Rheumatology, Clinical Research Centre, Harrow, United Kingdom.

Articles citing this

(truncated to the top 100)

Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med (2001) 9.70

Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med (1998) 6.12

Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J Exp Med (1999) 6.09

Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells. J Exp Med (1989) 5.65

Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J Exp Med (2000) 5.62

Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells. J Virol (2000) 4.87

Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. J Exp Med (1996) 4.70

Migration and maturation of Langerhans cells in skin transplants and explants. J Exp Med (1990) 4.48

Epstein-Barr virus-induced molecule 1 ligand chemokine is expressed by dendritic cells in lymphoid tissues and strongly attracts naive T cells and activated B cells. J Exp Med (1998) 3.72

In vivo requirement for Atg5 in antigen presentation by dendritic cells. Immunity (2010) 3.19

Primary stimulation by dendritic cells induces antiviral proliferative and cytotoxic T cell responses in vitro. J Exp Med (1989) 3.16

Dermal tumour necrosis factor-alpha induces dendritic cell migration to draining lymph nodes, and possibly provides one stimulus for Langerhans' cell migration. Immunology (1992) 3.09

Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization. J Exp Med (1998) 2.84

Early molecular events in the induction phase of contact sensitivity. Proc Natl Acad Sci U S A (1992) 2.77

Antigen acquisition by dendritic cells: intestinal dendritic cells acquire antigen administered orally and can prime naive T cells in vivo. J Exp Med (1993) 2.55

Langerhans cells and more: langerin-expressing dendritic cell subsets in the skin. Immunol Rev (2010) 2.44

CC chemokine receptor (CCR)2 is required for langerhans cell migration and localization of T helper cell type 1 (Th1)-inducing dendritic cells. Absence of CCR2 shifts the Leishmania major-resistant phenotype to a susceptible state dominated by Th2 cytokines, b cell outgrowth, and sustained neutrophilic inflammation. J Exp Med (2000) 2.40

Antigen processing by epidermal Langerhans cells correlates with the level of biosynthesis of major histocompatibility complex class II molecules and expression of invariant chain. J Exp Med (1990) 2.39

T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production: interferon gamma-producing (Tc1) effector CD8+ T cells and interleukin (Il) 4/Il-10-producing (Th2) negative regulatory CD4+ T cells. J Exp Med (1996) 2.16

Rapid cytotoxic T lymphocyte activation occurs in the draining lymph nodes after cutaneous herpes simplex virus infection as a result of early antigen presentation and not the presence of virus. J Exp Med (2002) 2.14

Dendritic cell ontogeny: a human dendritic cell lineage of myeloid origin. Proc Natl Acad Sci U S A (1997) 2.11

Class II major histocompatibility complex molecules of murine dendritic cells: synthesis, sialylation of invariant chain, and antigen processing capacity are down-regulated upon culture. Proc Natl Acad Sci U S A (1991) 2.06

Antigen-pulsed dendritic cells can efficiently induce an antibody response in vivo. J Exp Med (1992) 2.05

Characterization of sheep afferent lymph dendritic cells and their role in antigen carriage. J Exp Med (1989) 1.97

Endocytosis by antigen presenting cells: dendritic cells are as endocytically active as other antigen presenting cells. Proc Natl Acad Sci U S A (1992) 1.90

The antigen-presenting activities of Ia+ dendritic cells shift dynamically from lung to lymph node after an airway challenge with soluble antigen. J Exp Med (1995) 1.89

Tumour necrosis factor-alpha is required for accumulation of dendritic cells in draining lymph nodes and for optimal contact sensitization. Immunology (1995) 1.86

Differential roles of migratory and resident DCs in T cell priming after mucosal or skin HSV-1 infection. J Exp Med (2009) 1.76

Langerhans cells require signals from both tumour necrosis factor-alpha and interleukin-1 beta for migration. Immunology (1997) 1.76

Suppression of immune responses by dendritic cells infected with HIV. Immunology (1989) 1.61

Antigen capture and major histocompatibility class II compartments of freshly isolated and cultured human blood dendritic cells. J Exp Med (1995) 1.60

Keratinocytes function as accessory cells for presentation of endogenous antigen expressed in the epidermis. J Invest Dermatol (2009) 1.59

Mst1 controls lymphocyte trafficking and interstitial motility within lymph nodes. EMBO J (2009) 1.58

Macrophages and neutrophils are the targets for immune suppression by glucocorticoids in contact allergy. J Clin Invest (2007) 1.51

Increased DC trafficking to lymph nodes and contact hypersensitivity in junctional adhesion molecule-A-deficient mice. J Clin Invest (2004) 1.47

Phenotypic characteristics of antigen-bearing cells in the draining lymph nodes of contact sensitized mice. Immunology (1990) 1.46

The anatomy of T-cell activation and tolerance. Proc Natl Acad Sci U S A (1996) 1.42

Normal lymphatic development and function in mice deficient for the lymphatic hyaluronan receptor LYVE-1. Mol Cell Biol (2006) 1.42

MHC class II expression by Langerhans' cells and lymph node dendritic cells: possible evidence for maturation of Langerhans' cells following contact sensitization. Immunology (1991) 1.42

MHC class II expression restricted to CD8alpha+ and CD11b+ dendritic cells is sufficient for control of Leishmania major. J Exp Med (2004) 1.40

Monocyte-derived cultured dendritic cells are susceptible to human immunodeficiency virus infection and transmit virus to resting T cells in the process of nominal antigen presentation. J Virol (1995) 1.38

Dendritic cells route human immunodeficiency virus to lymph nodes after vaginal or intravenous administration to mice. J Virol (1998) 1.35

Semaphorins guide the entry of dendritic cells into the lymphatics by activating myosin II. Nat Immunol (2010) 1.33

Modulation of epidermal Langerhans' cell frequency by tumour necrosis factor-alpha. Immunology (1994) 1.33

CD40-CD40 ligand interactions in vivo regulate migration of antigen-bearing dendritic cells from the skin to draining lymph nodes. J Exp Med (2000) 1.33

Antigen-bearing dendritic cells in the draining lymph nodes of contact sensitized mice: cluster formation with lymphocytes. Immunology (1991) 1.31

Immunostimulant patch containing heat-labile enterotoxin from Escherichia coli enhances immune responses to injected influenza virus vaccine through activation of skin dendritic cells. J Virol (2003) 1.29

Osteopontin is involved in the initiation of cutaneous contact hypersensitivity by inducing Langerhans and dendritic cell migration to lymph nodes. J Exp Med (2001) 1.29

Induction of lung fibrosis in the mouse by intratracheal instillation of fluorescein isothiocyanate is not T-cell-dependent. Am J Pathol (1999) 1.28

Beyond immediate hypersensitivity: evolving roles for IgE antibodies in immune homeostasis and allergic diseases. Immunol Rev (2011) 1.28

In vivo activation of dendritic cells and T cells during Salmonella enterica serovar Typhimurium infection. Infect Immun (2001) 1.26

Systemic migration of dendritic cells during contact sensitization. Immunology (1990) 1.24

Defective dendritic cell migration and activation of adaptive immunity in PI3Kgamma-deficient mice. EMBO J (2004) 1.21

CCR2 plays a critical role in dendritic cell maturation: possible role of CCL2 and NF-kappa B. J Immunol (2010) 1.20

A unique dermal dendritic cell subset that skews the immune response toward Th2. PLoS One (2013) 1.17

The early expression of glycoprotein B from herpes simplex virus can be detected by antigen-specific CD8+ T cells. J Virol (2003) 1.16

Localization of DNA damage and its role in altered antigen-presenting cell function in ultraviolet-irradiated mice. J Exp Med (1996) 1.14

Endogenous galectin-3 is localized in membrane lipid rafts and regulates migration of dendritic cells. J Invest Dermatol (2008) 1.13

The inhibition of antigen-presenting activity of dendritic cells resulting from UV irradiation of murine skin is restored by in vitro photorepair of cyclobutane pyrimidine dimers. Proc Natl Acad Sci U S A (1997) 1.11

Identification of dendritic cells as a major source of interleukin-6 in draining lymph nodes following skin sensitization of mice. Immunology (1995) 1.11

The calcium-activated nonselective cation channel TRPM4 is essential for the migration but not the maturation of dendritic cells. Nat Immunol (2008) 1.10

The effect of ultraviolet B irradiation and urocanic acid isomers on dendritic cell migration. Immunology (1992) 1.09

Role of tumour necrosis factor-alpha in ultraviolet B light-induced dendritic cell migration and suppression of contact hypersensitivity. Immunology (1994) 1.09

Interleukin-10 secretion differentiates dendritic cells from human liver and skin. Am J Pathol (2004) 1.08

Essential role of lymph nodes in contact hypersensitivity revealed in lymphotoxin-alpha-deficient mice. J Exp Med (2001) 1.05

CD8 T cells producing IL-17 and IFN-gamma initiate the innate immune response required for responses to antigen skin challenge. J Immunol (2009) 1.05

Tumour necrosis factor receptor II (p75) signalling is required for the migration of Langerhans' cells. Immunology (1996) 1.03

Rat intestinal dendritic cells: immunostimulatory potency and phenotypic characterization. Immunology (1995) 1.01

IFN-beta inhibits dendritic cell migration through STAT-1-mediated transcriptional suppression of CCR7 and matrix metalloproteinase 9. J Immunol (2010) 0.98

Intranasal immunization with cytotoxic T-lymphocyte epitope peptide and mucosal adjuvant cholera toxin: selective augmentation of peptide-presenting dendritic cells in nasal mucosa-associated lymphoid tissue. Infect Immun (1998) 0.98

MGL2 Dermal dendritic cells are sufficient to initiate contact hypersensitivity in vivo. PLoS One (2009) 0.97

Dendritic cells and T cells transfer sensitization for delayed-type hypersensitivity after skin painting with contact sensitizer. Immunology (1989) 0.97

A silent chemokine receptor regulates steady-state leukocyte homing in vivo. Proc Natl Acad Sci U S A (2007) 0.96

Langerhans' cells produce type IV collagenase (MMP-9) following epicutaneous stimulation with haptens. Immunology (1997) 0.96

Evaluation of the sentinel immunized node for immune monitoring of cancer vaccines. Ann Surg Oncol (2008) 0.94

Dendritic cells of the oral mucosa and the induction of oral tolerance. A local affair. Immunology (1994) 0.94

Influence of ageing on Langerhans cell migration in mice: identification of a putative deficiency of epidermal interleukin-1beta. Immunology (2002) 0.93

Polysialylation controls dendritic cell trafficking by regulating chemokine recognition. Science (2015) 0.92

The effect of retinoids on dendritic cell function. Clin Exp Immunol (1989) 0.90

Protein kinase C transduces the signal for Langerhans' cell migration from the epidermis. Immunology (1993) 0.90

Regulation of immature dendritic cell migration by RhoA guanine nucleotide exchange factor Arhgef5. J Biol Chem (2009) 0.89

Differential function of dendritic cells isolated from blood and lymph nodes. Immunology (1994) 0.88

Neutral polymer micelle carriers with pH-responsive, endosome-releasing activity modulate antigen trafficking to enhance CD8(+) T cell responses. J Control Release (2014) 0.88

Expression and modulation of C5a receptor (CD88) on skin dendritic cells. Chemotactic effect of C5a on skin migratory dendritic cells. Immunology (1996) 0.87

Triptolide, a constituent of immunosuppressive Chinese herbal medicine, is a potent suppressor of dendritic-cell maturation and trafficking. Blood (2005) 0.87

Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model. PLoS One (2010) 0.87

Ultrastructural studies bearing on the mechanism of UVB-impaired induction of contact hypersensitivity to DNCB in man. Clin Exp Immunol (1993) 0.87

Nontoxic Shiga toxin derivatives from Escherichia coli possess adjuvant activity for the augmentation of antigen-specific immune responses via dendritic cell activation. Infect Immun (2005) 0.86

Modulation of the immune response with T-cell epitopes: the ultimate goal for specific immunotherapy of autoimmune disease. Immunology (1994) 0.86

Mycobacterium tuberculosis infection of human dendritic cells decreases integrin expression, adhesion and migration to chemokines. Immunology (2014) 0.86

Constitutive and inducible expression of interleukin-6 by Langerhans cells and lymph node dendritic cells. Immunology (1996) 0.86

Antigen presentation in the murine oral epithelium. Immunology (1996) 0.86

Antigen processing: cultured lymph-borne dendritic cells can process and present native protein antigens. Immunology (1995) 0.86

Class II antigens on dendritic cells from the synovial fluids of patients with inflammatory arthritis. Clin Exp Immunol (1989) 0.85

Tumour necrosis factor-alpha mediates ultraviolet light B-enhanced expression of contact hypersensitivity. Immunology (1992) 0.85

CD31 is a key coinhibitory receptor in the development of immunogenic dendritic cells. Proc Natl Acad Sci U S A (2014) 0.85

Antigenic competition in contact sensitivity. Evidence for changes in dendritic cell migration and antigen handling. Immunology (1990) 0.85

Tracking and quantification of dendritic cell migration and antigen trafficking between the skin and lymph nodes. Sci Rep (2014) 0.85

Progressor but not regressor skin tumours inhibit Langerhans' cell migration from epidermis to local lymph nodes. Immunology (1999) 0.85

T cell subsets in normal human epidermis. Am J Pathol (1996) 0.84

Articles cited by this

A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol (1973) 45.44

Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J Exp Med (1985) 11.14

Antigen-specific interaction between T and B cells. Nature (1985) 10.64

Antigen recognition by H-2-restricted T cells. I. Cell-free antigen processing. J Exp Med (1983) 6.97

A monoclonal antibody specific for mouse dendritic cells. Proc Natl Acad Sci U S A (1982) 5.77

Antigen-bearing langerhans cells in skin, dermal lymphatics and in lymph nodes. Cell Immunol (1976) 4.52

Epidermal Langerhans cell density determines whether contact hypersensitivity or unresponsiveness follows skin painting with DNFB. J Immunol (1980) 4.00

Dendritic cells and the initiation of contact sensitivity to fluorescein isothiocyanate. Immunology (1986) 3.25

STONE SH: Isologous and homologous lymphoid transplants. I. The transfer of tuberculin hypersensitivity in inbred pigs. J Immunol (1961) 2.86

A study of cells present in peripheral lymph of pigs with special reference to a type of cell resembling the Langerhans cell. Cell Tissue Res (1979) 2.85

Specialized antigen-presenting cells. Splenic dendritic cells and peritoneal-exudate cells induced by mycobacteria activate effector T cells that are resistant to suppression. J Exp Med (1982) 2.48

Accessory cell-T lymphocyte interactions. Antigen-dependent and -independent clustering. J Exp Med (1986) 2.47

The role of dendritic cells in the initiation of immune responses to contact sensitizers. I. In vivo exposure to antigen. Cell Immunol (1985) 2.43

Transfedotr of Allergic Encephalomyelitis by Lymph Node Cells in Inbred Guinea Pigs. Science (1961) 2.35

Functional anatomy of lymph nodes. II. Peripheral lymph-borne mononuclear cells. Anat Rec (1978) 2.21

Role of antigen-presenting cells in the development and persistence of contact hypersensitivity. J Exp Med (1980) 1.99

Relation between langerhans cells, veiled cells, and interdigitating cells. Immunobiology (1982) 1.94

Tolerance and contact sensitivity to DNFA in mice. VIII. Identification of distinct T cell subpopulations that mediate in vivo and in vitro manifestations of delayed hypersensitivity. J Immunol (1978) 1.92

Veiled cells--"dendritic cells" of the peripheral lymph. Immunobiology (1984) 1.86

Dendritic cells. Transplantation (1981) 1.72

Dendritic cells that have interacted with antigen are targets for natural killer cells. J Exp Med (1985) 1.68

Induction and regulation of contact hypersensitivity by resident, bone marrow-derived, dendritic epidermal cells: Langerhans cells and Thy-1+ epidermal cells. J Immunol (1986) 1.67

Conditions for measuring DNA synthesis in PHA stimulated human lymphocytes in 20 microliters hanging drops with various cell concentrations and periods of culture. J Immunol Methods (1980) 1.66

Delayed-type hypersensitivity is mediated by a sequence of two different T cell activities. J Immunol (1984) 1.65

Induction of cell-mediated immunity in the mouse: circumstantial evidence for highly immunogenic antigen in the regional lymph nodes following skin painting with contact sensitizing agents. Isr J Med Sci (1976) 1.63

The role of dendritic cells in the initiation of immune responses to contact sensitizers. II. Studies in nude mice. Cell Immunol (1985) 1.62

A simple technique for harvesting lymphocytes cultured in Terasaki plates. J Immunol Methods (1979) 1.58

A comparison of murine epidermal Langerhans cells with spleen dendritic cells. J Invest Dermatol (1985) 1.57

Characterization of two different Ly-1+ T cell populations that mediate delayed-type hypersensitivity. J Immunol (1984) 1.55

Contact hypersensitivity and Langerhans cells. J Invest Dermatol (1980) 1.51

Dermal and intravascular Langerhans cells at sites of passively induced allergic contact sensitivity. Cell Immunol (1975) 1.30

Contact sensitivity in the pig. Immunology (1973) 1.30

The role of the macrophage as the stimulator cell in contact sensitivity. J Immunol (1977) 1.28

The defect in delayed-type hypersensitivity of young adult SJL mice is due to a lack of functional antigen-presenting cells. Eur J Immunol (1985) 1.25

Contact and delayed hypersensitivity in the mouse. II. The role of different cell populations. Immunology (1969) 1.14

Anti-interleukin 2 receptor antibody suppresses delayed-type hypersensitivity to foreign and syngeneic antigens. J Immunol (1986) 1.12

Immunogenic cells in the regional lymph nodes after painting with the contact sensitizers picryl chloride and oxazolone: evidence for the presence of IgM antibody on their surface. Immunology (1983) 1.02

Dynamic changes in epidermal Ia-positive cells in allergic contact sensitivity reactions in mice. Br J Dermatol (1984) 1.01

Articles by these authors

Coral reefs under rapid climate change and ocean acidification. Science (2007) 26.35

Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. J Immunol (2001) 7.43

Evidence based purchasing: understanding results of clinical trials and systematic reviews. BMJ (1995) 4.75

Dendritic cells and the initiation of contact sensitivity to fluorescein isothiocyanate. Immunology (1986) 3.25

Primary stimulation by dendritic cells induces antiviral proliferative and cytotoxic T cell responses in vitro. J Exp Med (1989) 3.16

Neoplastic change in duplications of the alimentary tract. Br J Surg (1975) 2.77

Non-adherent, low-density cells from human peripheral blood contain dendritic cells and monocytes, both with veiled morphology. Immunology (1986) 2.72

In vivo cellular tropism of human T-cell leukemia virus type 1. J Virol (1990) 2.70

Identification of hematopoietic progenitors of macrophages and dendritic Langerhans cells (DL-CFU) in human bone marrow and peripheral blood. Blood (1990) 2.68

Induction of immune responses in vivo with small numbers of veiled (dendritic) cells. Proc Natl Acad Sci U S A (1983) 2.68

Dendritic cell infection, depletion and dysfunction in HIV-infected individuals. Immunology (1990) 2.58

Role of veiled cells in lymphocyte activation. Eur J Immunol (1982) 2.50

The role of dendritic cells in the initiation of immune responses to contact sensitizers. I. In vivo exposure to antigen. Cell Immunol (1985) 2.43

Susceptibility of human peripheral blood dendritic cells to infection by human immunodeficiency virus. J Gen Virol (1987) 2.38

Rationing and the health authority. BMJ (1998) 2.34

Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut (2004) 2.29

An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation. Am J Hum Genet (2006) 2.23

Functional anatomy of lymph nodes. II. Peripheral lymph-borne mononuclear cells. Anat Rec (1978) 2.21

Relation between a career and family life for English hospital consultants: qualitative, semistructured interview study. BMJ (2000) 2.04

Human peripheral blood contains two distinct lineages of dendritic cells. Eur J Immunol (1999) 2.01

Differential effect of IL-10 on dendritic cell-induced T cell proliferation and IFN-gamma production. J Immunol (1993) 2.00

Veiled cells--"dendritic cells" of the peripheral lymph. Immunobiology (1984) 1.86

The dendritic cell: its role in intestinal inflammation and relationship with gut bacteria. Gut (2003) 1.84

Mechanisms of action of probiotics: recent advances. Inflamm Bowel Dis (2009) 1.75

Conditions for measuring DNA synthesis in PHA stimulated human lymphocytes in 20 microliters hanging drops with various cell concentrations and periods of culture. J Immunol Methods (1980) 1.66

Primary hyperoxaluria type 1: genotypic and phenotypic heterogeneity. J Inherit Metab Dis (1994) 1.66

Migration and maturation of human colonic dendritic cells. J Immunol (2001) 1.64

The role of dendritic cells in the initiation of immune responses to contact sensitizers. II. Studies in nude mice. Cell Immunol (1985) 1.62

Failure in antigen responses by T cells from patients with common variable immunodeficiency (CVID). Clin Exp Immunol (1994) 1.61

Suppression of immune responses by dendritic cells infected with HIV. Immunology (1989) 1.61

Exceptional lymphocyte stimulating capacity of cells from lymphoid cell lines. Nature (1969) 1.60

The clinical features of homozygous alpha 2(I) collagen deficient osteogenesis imperfecta. J Med Genet (1984) 1.56

Sensitive in situ hybridisation technique using biotin-streptavidin-polyalkaline phosphatase complex. J Clin Pathol (1987) 1.56

Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56

Distribution of immunogenic cells after painting with the contact sensitizers fluorescein isothiocyanate and oxazolone. Different sensitizers form immunogenic complexes with different cell populations. Immunology (1980) 1.53

Immunologic reactivity in rheumatoid arthritis. Response to mitogens. Arthritis Rheum (1974) 1.52

Dendritic cells from patients with tropical spastic paraparesis are infected with HTLV-1 and stimulate autologous lymphocyte proliferation. AIDS Res Hum Retroviruses (1992) 1.45

Reduction of lymphocyte transformation by a factor produced by gastrointestinal cancer. Lancet (1973) 1.44

Searches for Lepton flavor violation in the decays tau{+/-}-->e{+/-}gamma and tau{+/-}-->mu{+/-}gamma. Phys Rev Lett (2010) 1.44

Men's health. BMJ (1996) 1.44

Defective low-density cells of dendritic morphology from the blood of patients with common variable hypogammaglobulinaemia: low immunoglobulin production on stimulation of normal B cells. Clin Exp Immunol (1985) 1.42

The health care needs of southeast asian refugees. Can Fam Physician (1988) 1.38

Type III collagen mutations in Ehlers Danlos syndrome type IV and other related disorders. Clin Exp Dermatol (1988) 1.38

The circulating immunoglobulins involved in protective immunity to the intestinal stage of Nippostrongylus brasiliensis in the rat. Immunology (1970) 1.36

Morphology and phenotype of dendritic cells from peripheral blood and their productive and non-productive infection with human immunodeficiency virus type 1. Immunology (1991) 1.36

Trial of three-day and ten-day courses of amoxycillin in otitis media. Br Med J (Clin Res Ed) (1982) 1.33

Isolation of viral haemorrhagic septicaemia virus from mummichog, stickleback, striped bass and brown trout in eastern Canada. J Fish Dis (2007) 1.31

Veiled (dendritic) cells in synovial fluid. Lancet (1983) 1.30

Antigen-presentation by macrophages but not by dendritic cells in human immunodeficiency virus (HIV) infection. Immunology (1992) 1.30

Experience with coeliac axis compression syndrome. Br Med J (1970) 1.30

Systemic migration of dendritic cells during contact sensitization. Immunology (1990) 1.24

Measurement of the electron charge asymmetry in inclusive W production in pp collisions at sqrt[s]=7  TeV. Phys Rev Lett (2012) 1.23

Primary proliferative and cytotoxic T-cell responses to HIV induced in vitro by human dendritic cells. Immunology (1991) 1.23

Accumulation of 111In-neutrophils in rabbit skin in allergic and non-allergic inflammatory reactions in vivo. Inhibition by neutrophil pretreatment in vitro with a monoclonal antibody recognizing the CD18 antigen. J Immunol (1989) 1.22

Demonstration of human papillomavirus types in paraffin processed tissue from human ano-genital lesions by in-situ DNA hybridisation. J Pathol (1987) 1.21

Ultrastructural appearance of freeze-substituted lymphocytes frozen by interrupting rapid cooling with a period at--26 degrees C. Cryobiology (1975) 1.21

T-cell-mediated enhancement of host-versus-graft reactivity in mice fed a diet enriched in vitamin A acetate. Nature (1983) 1.20

Search for new physics in the multijet and missing transverse momentum final state in proton-proton collisions at √s = 7 TeV. Phys Rev Lett (2012) 1.19

Actin may be present on the lymphocyte surface. Proc Natl Acad Sci U S A (1978) 1.19

Azimuthal anisotropy of charged particles at high transverse momenta in Pb-Pb collisions at sqrt[s(NN)] = 2.76  TeV. Phys Rev Lett (2012) 1.19

Characterisation of a barley (Hordeum vulgare L.) homologue of the Arabidopsis flowering time regulator GIGANTEA. Theor Appl Genet (2005) 1.18

Murine dendritic cells internalize Leishmania major promastigotes, produce IL-12 p40 and stimulate primary T cell proliferation in vitro. Eur J Immunol (1999) 1.17

Help and suppression by lymphoid cells as a function of cellular concentration. Proc Natl Acad Sci U S A (1979) 1.16

Perceptions related to bird-to-human avian influenza, influenza vaccination, and use of face mask. Infection (2008) 1.16

Suppression of collagen type II-induced arthritis by transfer of lymphoid cells from rats immunized with collagen. Clin Exp Immunol (1985) 1.15

Enzymological and mutational analysis of a complex primary hyperoxaluria type 1 phenotype involving alanine:glyoxylate aminotransferase peroxisome-to-mitochondrion mistargeting and intraperoxisomal aggregation. Am J Hum Genet (1993) 1.14

Primary human T-cell responses to the major outer membrane protein of Chlamydia trachomatis. Immunology (1993) 1.13

Production of interleukin (IL)-10 and IL-12 by murine colonic dendritic cells in response to microbial stimuli. Clin Exp Immunol (2005) 1.13

A prospective, randomized, parallel group, controlled study of the effect of intensity of speech and language therapy on early recovery from poststroke aphasia. Clin Rehabil (2007) 1.11

Separation of populations of human lymphocytes by freezing and thawing. Nat New Biol (1972) 1.10

Search for a W' or techni-ρ decaying into WZ in pp Collisions at sqrt[s] = 7  TeV. Phys Rev Lett (2012) 1.10

Optimal recovery of lymphocytes and tissue culture cells following rapid cooling. Nature (1974) 1.10

Evidence for an excess of B→D*τ(-)ν(τ) decays. Phys Rev Lett (2012) 1.10

Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn's disease. Gut (2005) 1.09

Changes in lymphoreticular tissues during growth of a murine adenocarcinoma. I. Histology and weight of lymph nodes, spleen, and thymus. J Natl Cancer Inst (1971) 1.09

Search for new physics with same-sign isolated dilepton events with jets and missing transverse energy. Phys Rev Lett (2012) 1.09

Observation of time-reversal violation in the B0 meson system. Phys Rev Lett (2012) 1.09

Double-blind controlled trial of immunosuppression in the treatment of multiple sclerosis: final report. Lancet (1982) 1.09

The effect of immunity upon some enzymes of the parasitic nematode, Nippostrongylus brasiliensis. Parasitology (1971) 1.08

Dendritic cells infected in vitro with human T cell leukaemia/lymphoma virus type-1 (HTLV-1); enhanced lymphocytic proliferation and tropical spastic paraparesis. Clin Exp Immunol (1993) 1.08

Protection against ascending infection of the genital tract by Chlamydia trachomatis is associated with recruitment of major histocompatibility complex class II antigen-presenting cells into uterine tissue. Infect Immun (1998) 1.07

Precise measurement of the e+e- --> pi+pi-(gamma) cross section with the initial state radiation method at BABAR. Phys Rev Lett (2009) 1.07

Subcellular distribution of hepatic alanine:glyoxylate aminotransferase in various mammalian species. J Cell Sci (1990) 1.07

Red cell membrane protein distribution during malarial invasion. J Cell Sci (1989) 1.07

Origins of the parasitophorous vacuole membrane of the malaria parasite, Plasmodium falciparum, in human red blood cells. J Cell Sci (1992) 1.06

Identification of novel deletion breakpoints bordered by segmental duplications in the NF1 locus using high resolution array-CGH. J Med Genet (2005) 1.06

Double-blind, controlled trial of immunosuppression in treatment of multiple sclerosis. Lancet (1980) 1.06

Retrovirally induced switch from production of IL-12 to IL-4 in dendritic cells. Eur J Immunol (1999) 1.05

Measurement of |V(cb)| and the form-factor slope in B --> Dl- nu(l) decays in events tagged by a fully reconstructed B meson. Phys Rev Lett (2010) 1.05

Quantification and cytokine production of circulating lymphoid and myeloid cells in acute myelogenous leukaemia. Leukemia (2003) 1.04

Molecular cloning of MADM: a catalytically active mammalian disintegrin-metalloprotease expressed in various cell types. Biochem J (1996) 1.04

Class II histocompatibility antigens on human dendritic cells. Immunology (1987) 1.03

Changes in the populations of lymphoid cells in human peripheral blood following physical exercise. Clin Exp Immunol (1984) 1.03